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Abstract 22 
Background: Dendritic cells (DCs) are key players in the induction and re-elicitation of Th2 23 
immune responses to allergens. We have previously shown that different C-type lectin 24 
receptors on DCs play a major role in allergen recognition and uptake and downstream events 25 
leading to allergic sensitization. In particular, mannose receptor (MR), through modulation of 26 
TLR4 signalling, can regulate indoleamine 2,3 dioxygenase (IDO) activity favouring Th2 27 
immune responses. Interestingly, the aryl-hydrocarbon receptor (AhR), a ligand-dependent 28 
transcription factor with an emerging role in immune modulation, has been implicated in IDO 29 
activation in response to TLR stimulation.  30 
Objective: Here we investigated how allergens and lectins through MR can modulate the 31 
TLR4-AhR-IDO axis in human monocyte-derived DCs.  32 
Methods: Using a combination of genomics, proteomics techniques and immunological 33 
studies, we investigated the role of MR and AhR in IDO regulation and its impact on T helper 34 
cell differentiation.  35 
Results: We have demonstrated that LPS induces both IDO isoforms i.e. IDO1 and IDO2 in 36 
human DCs with partial involvement of AhR. Additionally, we found that like mannan airborne 37 
allergens from diverse sources can effectively down-regulate the TLR4-induced IDO1 and 38 
IDO2 expression, most likely through biding to the MR. Mannose-based ligands were also able 39 
to down-regulate IL-12p70 production by DCs affecting T helper cell polarization. 40 
Interestingly, AhR and some key components of the non-canonical NF-κB pathway were 41 
shown to be down-regulated after MR engagement, which could explain regulatory effects of 42 
the MR on IDO expression.  43 
Conclusion: Our work demonstrates a key role for MR in the modulation of the TLR4-IDO-44 
AhR axis, which clearly has a significant impact on DC behaviour and the development of 45 
immune responses against allergens. 46 
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Key messages 47 
 TLR4 induction of IDO1 and IDO2 is down-regulated by airborne allergens through the 48 
mannose receptor in human dendritic cells changing their immune-regulatory properties. 49 
 IDO regulation in human DCs is partially dependent on the aryl-hydrocarbon receptor, a 50 
ligand-dependent transcription factor involved in sensing intracellular or environmental 51 
changes, with participation of the non-canonical NF-κB pathway. 52 
Capsule summary 53 
This article demonstrates that several airborne allergens down-regulate both IDO isoforms in 54 
human DCs with a mechanism likely through binding to the mannose receptor. This process 55 
involves the aryl-hydrocarbon receptor and the NF-κB pathway. This work therefore highlights 56 
novel targets that can be used for modulating allergen-driven Th2 immune responses.  57 
Key words  58 
Dendritic cells, allergy, T helper 2, indoleamine 2,3-dioxygenase, C-type lectin receptor, 59 
mannose receptor, TLR4, aryl-hydrocarbon receptor, NF-κB. 60 
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Introduction 69 
Allergic diseases are typically characterized by an exacerbated immune response against 70 
allergens leading to Th2 polarization and production of allergen-specific IgE. Despite recent 71 
advances, the early events leading to allergic sensitization and the elicitation of Th2 immune 72 
responses are still unclear. Dendritic cells (DCs) are specialized antigen presenting cells that 73 
play an important role in the induction and re-elicitation of Th2-allergic immune responses 74 
(1-4). Recent work by us and others have shown that C-type lectin receptors (CLRs) such as 75 
mannose receptor (MR) and Dendritic cell-specific intracellular adhesion molecule 3-76 
grabbing non-integrin (DC-SIGN) play a major role in the recognition and uptake of 77 
allergens, the initial steps leading to allergic sensitization (1, 5-10). Interestingly, under 78 
certain conditions, DC-SIGN and MR ligation can have opposing effects on T cell 79 
polarization (5, 6). MR is a multifunctional endocytic receptor with two independent 80 
carbohydrate-binding domains that recognize sulfated and mannosylated structures, 81 
respectively (11). Several studies have demonstrated that CLR activation can modulate 82 
pattern recognition receptor-induced activation, particularly TLR4 signaling, and the 83 
downstream events leading to Th2 cell polarization (1, 5, 12-16). We have previously shown 84 
that Der p 1, the main allergen from house dust mite (HDM), in the presence of low levels of 85 
LPS down-regulates indoleamine 2,3-dioxygenase (IDO) through engagement of MR on 86 
human DCs leading to a Th2 immune response (5). This data shows the involvement of MR 87 
in inducing Th2-allergic immune responses through regulation of IDO activity in human DCs 88 
with the participation of TLR4 signaling however the exact mechanism remains unclear.  89 
IDO is an enzyme that catalyzes the degradation of the essential amino acid tryptophan (TRP) 90 
into N-formyl-kynurenine, the first and rate-limiting step of TRP catabolism in the 91 
kynurenine pathway (17, 18). IDO has been demonstrated to be involved in diverse immune-92 
regulatory processes in health and disease (17, 18). In particular, it has been shown that IDO 93 
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has a protective role in several models of experimental asthma (19-24). Furthermore, clinical 94 
studies have shown that asymptomatic non-atopic individuals have higher systemic IDO 95 
activity than symptomatic atopic individuals which might support the notion of IDO as a 96 
protector against allergy (25, 26). However, the mechanism of IDO regulation in these 97 
models particularly in a human context has remained elusive.  98 
Aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor involved in 99 
sensing intracellular or environmental changes (27). Kynurenine (KYN), one of the main 100 
metabolites produced in the IDO-dependent TRP degradation pathway, can activate AhR 101 
leading to the generation of regulatory T cells (Treg) (28). In addition, previous observations 102 
in mouse DCs have suggested that AhR mediates IDO induction in response to TLR agonists 103 
(29, 30). Here we sought to investigate how allergens modulate the crosstalk between MR 104 
and TLR4 in the context of IDO and to establish whether AhR plays a role in IDO regulation 105 
in human DCs. We have demonstrated that different airborne allergens, most likely through 106 
biding to MR, can significantly down-regulate TLR4 induction of IDO and impair DC 107 
response to LPS as evidenced by suppression of IL-12 production and primingTh1 responses. 108 
Furthermore, we show for the first time the co-regulation of AhR and components of the non-109 
canonical nuclear factor-kappaB (NF-κB) pathway with IDO expression, suggesting that a 110 
functional and/or physical association between them could be involved in IDO regulation in 111 
human DCs. These data further highlights the intrinsic immuno-modulatory properties of 112 
allergens through engaging CLRs and can help better understanding of how allergens can 113 
modulate DC behavior and bias T cell responses towards Th2 immune phenotype. 114 
 115 
 116 
 117 
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Material and Methods 118 
Generation of human DCs from blood samples 119 
Buffy coat samples were obtained from healthy volunteers after obtaining informed written 120 
consent and approval of local ethics committee (National Blood Service, Sheffield, UK). DCs 121 
were generated as described before (5, 31). Briefly, peripheral blood mononuclear cells were 122 
separated by density gradient centrifugation on Histopaque (Sigma-Aldrich). CD14+ 123 
monocytes were isolated from PBMCs by positive selection using a magnetic cell separation 124 
system (Miltenyi Biotech, UK) (purity >95%) and were then seeded in RPMI 1640 medium 125 
(Sigma-Aldrich) supplemented with 10%v/v heat inactivated Foetal Bovine Serum, 100 U/ml 126 
penicillin - 100 µg/ml streptomycin and 2 mM L-Glutamine (all from Sigma-Aldrich). 127 
Monocyte differentiation into DCs was carried out for 6 days in the presence of 50 ng/ml 128 
GM-CSF and 250 U/ml IL-4 (both from Miltenyi Biotech). Human peripheral blood myeloid 129 
DCs were isolated using the CD1c+ dendritic cell isolation kit (Miltenyi Biotech) according 130 
to manufacturer’s instructions.  131 
Quantification of IDO activity 132 
DCs (2.5x105 cells/ml) were seeded in a 24-well plate with complete media supplemented 133 
with 100 µM L-TRP (Sigma-Aldrich). After stimulation, IDO activity was measured by 134 
quantification of the levels of KYN in the culture supernatant using a colorimetric assay as 135 
we have described previously (5). Allergen extracts were purchased from Greer Labs, USA. 136 
Typical exotoxin content of HDM preparations was 26.1 EU/mg protein. 137 
Flow cytometry analysis 138 
Antibodies (Abs) against IFN-γ (clone B27), IL-4 (clone MP4-25D2) and MR (clone 19.2) 139 
were purchased from Biolegend, UK. Abs against CD80 (clone MAB104), CD83 (clone 140 
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HB15a), CD86 (clone HA5.2B7), MHC-II (clone Immu-357), CD4 (clone 13B8.2) and DC-141 
SIGN (clone AZND1) were purchased from Beckman coulter, UK. Abs against PDL2 (clone 142 
MIH18), PDL1 (clone MIH1) and ICOSL (clone 2D3/B7-H2) were purchased from BD 143 
Biosciences. Ab against AhR (clone FF3399) was purchased from eBioscience, UK. Ab 144 
against IDO1 (clone 700838) was purchased from R&D Systems, UK. Ab against TLR4 145 
(clone HTA125) was purchased from AbD serotec, UK. Nonreactive isotype-matched Abs 146 
were used as controls. Briefly, cells were harvested and washed twice with PBA (PBS 147 
containing 0.5% BSA and 0.1% sodium azide) (all from Sigma-Aldrich). At this point surface 148 
staining was done for 20 min at 4°C. For intracellular staining, cells were fixed for 10 min at 149 
room temperature with formaldehyde 4% (Sigma-Aldrich). They were then washed twice 150 
with permeabilization/wash buffer (PBA containing 0.5% saponin (Sigma-Aldrich)), stained 151 
for 30 min at 4°C and washed twice in the same buffer before analysis in an FC 500 Flow 152 
Cytometer (Beckman Coulter) (32). Intracellular staining for cytokines was analysed in a 153 
MoFlo XDP Flow Cytometer (Beckman Coulter). All data analysis was done using Weasel 154 
Software. 155 
mRNA isolation, cDNA synthesis and PCR 156 
Cells were washed twice in ice-cold PBS and total RNA extraction was carried out using the 157 
RNeasy Plus Minikit (Qiagen, UK) according to manufacturer’s instructions. Samples were 158 
then DNase treated using the TURBO DNA-free kit (Thermo Fisher Scientific) and total 159 
RNA was concentrated through ethanol precipitation. cDNA was synthesized from total RNA 160 
using superscript III first-strand synthesis kit (Thermo Fisher Scientific) according to 161 
manufacturer’s instructions.  162 
Conventional PCR was carried out in a TC-312 PCR Thermocycler (Bibby Scientific Ltd, 163 
UK) using the Phusion Flash High-Fidelity PCR Master Mix (Thermo Fisher Scientific). 164 
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Cycling was initiated at 98°C for 10 secs, followed by 30 cycles of 98°C for 1 sec, 64°C for 5 165 
secs and 72°C for 15 secs, the final extension was done at 72°C for 1 min. Then, the PCR 166 
products were analysed in an E-gel pre-cast 2% agarose electrophoresis system (Thermo 167 
Fisher Scientific). 168 
Quantitative real time PCR was performed in a Strategene MxPro 3005P qPCR System with 169 
the Brilliant III Ultra-Fast SYBR Green qPCR Master Mix (Agilent Technologies, USA). 170 
Cycling was initiated at 95°C for 3 min, followed by 40 cycles of 95°C for 20 secs and 60°C 171 
for 20 secs, a melting curve was done at the end. Samples were run in triplicates, and relative 172 
expression was calculated using the comparative threshold cycle method, also known as the 173 
ΔΔCt method, normalized to GAPDH (33, 34).  174 
Primers were obtained from Eurofin, UK: Glyceraldehyde 3-phosphate dehydrogenase 175 
(GAPDH) Forward (5`-GAGTCAACGGATTTGGTCGT-3`), GAPDH Reverse (5`-176 
GACAAGCTTCCCGTTCTCAG-3`), IDO1 Forward (5`-GGCACACGCTATGGAAAACT-177 
3`), IDO1 Reverse (5`- GAAGCTGGCCAGACTCTATGA-3`), IDO2 Forward (5’-178 
CTGATCACTGCTTAACGGCA-3’), IDO2 Reverse (5’-TGCCACCAACTCAACACATT-179 
3’), AhR Forward (5’-ATCACCTACGCCAGTCGCAAG-3’), AhR Reverse (5’-180 
AGGCTAGCCAAACGGTCCAAC-3’), CYP1A1 Forward (5’-181 
CACAGACAGCCTGATTGAGCA-3’), CYP1A1 Reverse (5’-182 
GTGTCAAACCCAGCTCCAAAGA-3’), RelB Forward (5’- 183 
TCGTCGATGATCTCCAATTCAT-3’), RelB Reverse (5’- 184 
CCCCGACCTCTCCTCACTCT-3’), MR Forward (5’-CGTTTACCAAATGGCTTCGT-3’) 185 
and MR Reverse (5’-CCTTGGCTTCGTGATTTCAT-3’). 186 
Cytokine measurements 187 
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Cell-free supernatants were collected and stored at -20°C before analysis. Cytokine (IL-6, IL-188 
10, IL-12p70, TGF-β and IFN-α) concentration was analysed using the ProcartaPlex 189 
Multiplex Immunoassay system (eBioscience) according to manufacturer’s instructions.  190 
RNA interference 191 
Small interfering RNA (siRNA) was carried out as previously described with slight 192 
modification (5, 6). MR and AhR siRNA were the SMARTpool: ON-TARGETplus siRNA 193 
from GE Healthcare, UK. The control siRNA was the ON-TARGETplus Non-targeting 194 
control from GE Healthcare. Monocytes were transfected on day 0 with 50 nM siRNA using 195 
the DharmaFECT 2 Transfection Reagent (GE Healthcare). The inhibition was assessed at 196 
day 6.  197 
Reverse phase protein microarray 198 
After stimulation, DCs were washed twice with ice-cold PBS and lysed in 60 µl of RIPA 199 
buffer containing protease and phosphatase inhibitors (all from Thermo Fisher Scientific). 200 
For reverse phase protein microarray the procedure described in Negm et al. was followed 201 
(35). After denaturation, samples were spotted onto nitrocellulose-coated glass slides (Grace 202 
Bio-labs) with a microarray robot (MicroGrid 610, Digilab). Then, slides were incubated 203 
overnight in blocking solution (0.2% I-Block (Thermo Fisher Scientific), 0.1% Tween-20 in 204 
PBS (Sigma-Aldrich) at 4ºC. After washing, slides were incubated with primary Abs 205 
overnight at 4ºC. β-actin Ab was included as a loading control. All Abs were purchased from 206 
Cell Signaling Technologies. After washing, slides were incubated with infrared Licor 207 
secondary abs for 30 min at room temperature in the dark. Finally, slides were scanned with a 208 
Licor Odyssey scanner (LI-COR, Biosciences). The resultant TIFF images were processed 209 
with Genepix Pro-6 Microarray Image Analysis software (Molecular Devices Inc.). Protein 210 
signals were finally determined with background subtraction and normalization to the internal 211 
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housekeeping targets. Signal values represented on the colour scale for the heat map are log2 212 
transformed from the arbitrary fluorescence units (AFU) and normalized by using the 213 
standard deviation. Heat maps were generated using TMEV software.  214 
DC-T cell co-culture 215 
Human DCs were treated or not with mannan (10 µg/ml) (Sigma-Aldrich) and co-cultured in 216 
the presence of LPS (0.01 µg/ml) (Sigma-Aldrich) in 96-well U-bottom plate (Corning Life 217 
Sciences) with CD3+CD45RA+ autologous naïve T cells (DC-Tc ratio 1:10) purified by 218 
immunomagnetic cell sorting (Miltenyi Biotech) in RPMI 1640 supplemented with 5% 219 
human AB serum, 100 U/ml penicillin - 100 µg/ml streptomycin and 2 mM L-Glutamine (all 220 
from Sigma-Aldrich). After 3-4 days, IL-2 (5 ng/ml) (R&D Systems) with fresh media was 221 
added to the co-culture. After another 3-4 days, T cells were restimulated with anti-CD3 222 
(Sigma-Aldrich) and anti-CD28 (2 µg/ml) for 18 hrs (AbD serotec). For intracellular staining, 223 
brefeldin-A (10 µg/ml) (Sigma-Aldrich) was added after 2 hrs and the production of IL-4 and 224 
IFN-γ was detected on CD4+ cells using specific abs. Quadrants were set in a way that 99.5% 225 
of the cells were in the bottom or left quadrant in the fluorescence minus one (FMO) controls 226 
accordingly. 227 
Statistical analysis 228 
Values of the mean ± SEM are shown unless otherwise stated. ANOVA or Student t Test was 229 
applied: *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001. For all statistical analysis 230 
GraphPad Prism 5 Software was used. 231 
 232 
 233 
 234 
 235 
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Results  236 
TLR4 agonist induce IDO1 and IDO2 in human dendritic cells  237 
Our data clearly show that LPS on its own can effectively induce the expression of both IDO 238 
isozymes (IDO1 and IDO2) and IDO activity in human monocyte-derived DCs as well as in 239 
peripheral blood myeloid DCs (Fig. 1A, B, C, D, E). This is in contrast with previous reports 240 
where co-stimulation with either IFN- or prostaglandin E2 was deemed to be essential (36-241 
39). Additionally, this effect was observed with LPS from different bacterial sources, such as 242 
E.coli and S.minnesota (Fig. 1A and data not shown). Some LPS preparations are thought to 243 
be contaminated with small quantities of other bacterial components that could also activate 244 
TLR2 signaling. To confirm that the outcome on IDO was mediated by TLR4 engagement, 245 
we tested the effect of ultrapure LPS as well as the synthetic diacylated lipoprotein (FSL-1) 246 
as a specific TLR2 agonist. Our data showed similar dose-dependent effect induced by 247 
increasing concentrations of ultrapure LPS (Fig. 1B), while FSL-1 did not affect IDO activity 248 
in human DCs (data not shown). Interestingly, our data also show a ‘bell-shaped’ dose 249 
response for IDO activity after TLR4 activation with LPS from E.coli, with high levels (10 250 
µg/ml) inducing less IDO activity than low levels (0.1 µg/ml) in human DCs. However, this 251 
was not the case for ultrapure LPS, where we observed a dose dependent induction of IDO 252 
activity in human DCs. The effect of LPS was not associated with cellular death as high 253 
levels of LPS did not affect cell viability quantified by the presence of annexin-V and 254 
propidium iodine (data not shown). 255 
TLR4-induction of IDO1 and IDO2 is down-regulated by allergens from diverse sources 256 
After establishing the role of LPS in IDO regulation, we investigated how different allergen 257 
extracts i.e. House Dust Mite (HDM) extract from Dermatophagoides pteronyssinus, German 258 
Cockroach (GC) extract from Blattella germanica and Bermuda Grass Pollen (BGP) extract 259 
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from Cynodon dactylon can modulate IDO activity in the presence and absence of LPS. A 260 
slight down-regulation in IDO activity levels were observed when human DCs were exposed 261 
to allergen extracts alone but this did not reach statistical significance. However, allergen 262 
extracts from HDM, cockroach and pollen were able to significantly reduce LPS-driven up-263 
regulation of IDO in human DCs (Fig. 2A). 264 
We have previously shown that many allergens from diverse sources (including HDM and 265 
cockroach) are heavily mannosylated (7) and such sugar moieties play a key role in CLR 266 
mediated allergen recognition and uptake by DCs (1, 7) . Accordingly, we studied the impact 267 
of highly mannosylated sugars in IDO regulation using mannan as a prototypic high mannose 268 
carbohydrate that can be recognized by MR (40, 41). Here we have shown that mannan is 269 
able to down-regulate both IDO1 and IDO2 gene expression and activity in human DCs (Fig. 270 
2B, C). This data suggests a key role for carbohydrates in allergen preparations in modulating 271 
IDO in human DCs.  272 
Mannose-based ligands down-regulate TLR4-induced IL-12p70 production in human 273 
dendritic cells and affect T helper cell polarization  274 
Several cytokines have been linked with IDO regulation. Particularly, IL-10, TGF-β and 275 
type-I IFNs have been associated with IDO induction (18, 25, 42), while IL-6 has been shown 276 
to be involved in IDO degradation (18). Additionally, it has been suggested that specific MR 277 
agonists, such as the mannose-capped lipoarabinomannans (Man-LAM), can negatively 278 
regulates TLR4-dependent IL-12 production in mouse macrophages (43). Accordingly, we 279 
studied how these cytokines are regulated by mannan in human DCs. No significant 280 
differences were found when DCs were stimulated with mannan alone compared to un-281 
stimulated DCs (Fig. 3A). However, the presence of mannan significantly reduced IL-12p70 282 
production after LPS stimulation compared with LPS alone (Fig. 3A). Similar results were 283 
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found after stimulating DCs with LPS in the presence of HDM, cockroach and pollen extracts 284 
(Fig. 3B). Subsequently, we evaluated how different costimulatory receptors were regulated 285 
under these conditions. No significant differences were found for most of the receptors tested, 286 
except a significant down-regulation in CD86 expression (Fig. 3C).  287 
We then performed co-culture experiments using DCs pre-stimulated with either mannan 288 
and/or LPS prior to co-culture with autologous naïve T cells. Our data shows a significant 289 
reduction in IFN-γ production by T cells that were co-cultured with ‘mannan+LPS’ primed 290 
DCs compared to LPS only controls (Fig. 3D, E, F). This reduction in IFN- was not due to 291 
reduced cell viability and was reflected in both percentage of IFN-γ producing cells and level 292 
of IFN- measured in the culture supernatant (Fig. 3D, E). Given the non-atopic status of 293 
donors, not surprisingly we did not detect high levels of IL-4 producing T cells except in one 294 
donor where there was a significant increase in the percentage of IL-4 producing cells in 295 
‘mannan+LPS’ condition (data not shown). Taken together, these results show that allergen 296 
extracts and mannan can down regulate IDO in DCs and suppress Th1 polarization.  297 
Mannose receptor mediates the IDO down-regulation by mannose-based ligands 298 
Since MR is not the only receptor involved in the recognition of mannosylated structures on 299 
DCs, we sought to determine the role of MR in mannan-mediated modulation of IDO activity 300 
in human DCs. Using small interfering RNA (siRNA) we could knockdown MR expression 301 
on DCs by up to 80% similar to our previous work (5) (Suppl. Fig. 1). Control (CT) and 302 
MRlow-DCs were stimulated with mannan with or without LPS and IDO activity was 303 
measured after 24 hrs culture. This data clearly show an increase in IDO activity in MRlow-304 
DC compared with CT-DC indicating that MR plays a key role in the IDO down-regulation 305 
induced by mannan in human DCs (Fig. 4A). Additionally, we found an inverse correlation 306 
between the expression of MR and IDO1 in DCs stimulated with mannan and LPS (Fig. 4B). 307 
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A reduction in IDO1 levels was associated with an increase in MR expression in DCs 308 
stimulated with mannan. These data suggest that mannosylated allergens down-regulate IDO 309 
through MR engagement in human DCs.  310 
IDO regulation in human dendritic cells is partially dependent on AhR 311 
In order to study the role of the receptor-transcription factor AhR in the induction of IDO in 312 
human DCs, we generated AhRlow-DCs through gene silencing (Suppl. Fig. 2) and analyzed 313 
IDO activity after TLR4 stimulation compared with CT-DCs. Our data shows a lack of IDO 314 
up-regulation in AhRlow-DCs compared with CT-DCs after TLR4 engagement (Fig. 5A), 315 
which suggests that LPS-mediated IDO induction in human DCs is partially dependent on 316 
AhR expression. Accordingly, we next sought to evaluate how AhR expression and activity 317 
were regulated after stimulating DCs with mannan in the presence and absence of LPS. When 318 
DCs were stimulated with mannan and LPS, AhR expression and activity, assessed by 319 
measuring the expression of one of its target genes i.e. cytochrome P450 1A1 (CYP1A1), 320 
were significantly reduced compared with DCs stimulated with LPS alone (Fig. 5B). This 321 
shows that MR engagement can interfere with TLR4 signaling by modulating the AhR-IDO 322 
axis in human DCs.  323 
Furthermore, we found that IL-10 production, as well as IDO activity, were significantly 324 
lower in AhRlow-DCs than in CT-DCs, while IL-12p70 production, a key cytokine involved 325 
in Th1 polarization, was not affected (Fig. 5C). This data shows, for the first time, the 326 
important role of AhR in TLR4 signaling in human DCs, specifically in their regulatory 327 
functions, such as those mediated by IDO and IL-10 production.  328 
The NF-κB pathway is negatively regulated by MR in human dendritic cells 329 
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The NF-κB pathway plays a central role in driving immunity and inflammation. TLR4 330 
signaling induces canonical NF-κB pathway resulting in p65 phosphorylation, nuclear 331 
translocation and induction of pro-inflammatory cytokine expression that activate the 332 
immune response (44). On the other hand, IDO induction has been shown to be under the 333 
control of the non-canonical NF-κB pathway (36, 42, 45) involving the generation of p52-334 
RelB complexes (44, 46). Accordingly, we evaluated how MR modulates both the canonical 335 
and non-canonical NF-κB pathway in human DCs. In order to understand how different 336 
components of the NF-κB pathway were regulated upon TLR-4 activation (in the presence 337 
and absence of mannan) we used a reverse phase protein array approach (35) that enables 338 
simultaneous evaluation of protein expression as well as post-translational modifications. 339 
First, we evaluated a panel of 14 different targets at different time points (10, 30, 90, 360 and 340 
1080 min), using β-actin as a housekeeping control. Green (low expression) to red (high 341 
expression) heat maps represent the relative abundance of proteins upstream of the canonical 342 
and non-canonical NF-κB signalling pathway (Fig. 6A). DCs stimulated with LPS exhibited a 343 
rapid induction in p65 phosphorylation with a peak at 90 min (canonical NF-κB activation), 344 
which was followed by NIK accumulation between 6 to 18 hrs (a classical indicator of non-345 
canonical NF-κB activation) (Fig. 6A, B). However, mannan on its own did not induce NF-346 
κB activation (data not shown). Main differences were found in the levels of phospho-p65 as 347 
well as the expression of RelB in DCs stimulated with mannan plus LPS compared to LPS 348 
only (Fig. 6 A, B, C). DCs stimulated with mannan and LPS showed a significant decrease in 349 
a component of the non-canonical NF-κB pathway namely RelB (Fig. 6B, C), which was 350 
further confirmed at gene level by qRT-PCR (Fig. 6D). In addition, a decrease was observed 351 
in phospho-p65 at late time points (Fig. 6B, C). Taken together, these data show that MR 352 
ligation in human DCs impairs NF-κB activation in the presence of LPS. This antagonistic 353 
effect of MR on TLR4 activation of non-canonical NF-κB pathway could explain the effect 354 
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on the AhR-IDO axis described above, which perhaps might involve a physical and 355 
functional association between AhR and RelB in modulating IDO levels in human DCs. 356 
 357 
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Discussion 374 
Asthma is a common chronic inflammatory disease of the conducting airways that affects 375 
millions of people worldwide. Allergic asthma is characterized by Th2 cell differentiation 376 
and the presence of IgE antibodies against common inhaled allergens. DCs have been shown 377 
to be pivotal in the early events such as allergen recognition and uptake which lead to Th2 378 
polarization and ultimately allergic sensitization, however, how allergens modulate DCs 379 
functions and downstream T cell responses is not clear (1-4). Previous observations have 380 
shown that TLR4 signaling is crucial for inducing Th2-mediated inflammation and asthma 381 
(47-49) which is dependent on the levels of LPS exposure (49). It is therefore reasonable to 382 
assume that allergens could potentially modulate DC response to LPS in favor of Th2 383 
responses. LPS-induced programming of human DCs is characterized by a rapid increase in 384 
pro-inflammatory cytokines, followed by induction of anti-inflammatory mediators that help 385 
to resolve inflammation. One of the key molecules that mediate immuno-regulatory function 386 
in DCs is the TRP-metabolizing enzyme IDO (17, 18). In this study we first established how 387 
IDO is regulated in human DCs in response to TLR-4 agonist LPS showing IDO up-388 
regulation in response to relatively low concentrations of LPS (up to 100 ng/ml) followed by 389 
reduction in IDO at higher concentrations (Fig. 1A, B, C, D, E). These data were confirmed 390 
after using ultrapure LPS establishing the involvement of TLR4 pathway only (Fig. 1B). Two 391 
IDO isozymes have been identified namely IDO1 and IDO2 (50), with IDO1 being the most 392 
extensively studied. Both genes have similar structures and are situated adjacent to each other 393 
on human chromosome 8. Although both proteins have similar enzymatic activity, there are 394 
different expression patterns in some pathological condition (51-53). Here we have shown for 395 
the first time that both IDO isozymes are induced after TLR4 engagement (Fig. 1D).  396 
We and others have previously shown that CLRs such as MR and DC-SIGN are key 397 
receptors involved in allergen recognition by DCs and in downstream events leading to Th2 398 
18 
 
cell polarization (1, 5, 6, 8, 10, 54). In the case of MR this is likely to be mediated through 399 
down-regulation of IDO activity (5) however the molecular mechanisms of how MR ligation 400 
modulates IDO activity remained unclear. In the current study, using siRNA (Suppl. Fig. 1), 401 
we have shown that MR mediates the allergen (and mannan) induced down-regulation of 402 
IDO activity in LPS stimulated DCs (Fig. 4A, B). This data demonstrates the ability of a 403 
number of clinically relevant allergen extracts from diverse sources, such as HDM, cockroach 404 
and pollen in down-regulating LPS induced IDO activity and the importance of carbohydrates 405 
in this process (Fig. 2A, B, C). Admittedly not all allergens are necessarily glycosylated (e.g. 406 
lipocalins) however it is still worth investigating IDO regulation by such families of allergens 407 
given their proven ability in enhancing innate immune signaling by modulating TLR4 408 
activation (55, 56).  409 
Furthermore, we studied how MR engagement might modulate other aspects of DC function. 410 
Our data showed that mannosylated sugars can particularly down-regulate TLR4-mediated 411 
IL-12p70 production, a key cytokine in Th1 polarization (Fig. 3A). This shows an 412 
antagonistic effect between MR and TLR4 which was in line with previous observations (41, 413 
43, 57, 58). A similar pattern was found with all the allergen extracts tested suggesting that 414 
the mannosylated sugars on them are responsible for the modulation of IL-12p70 production 415 
(Fig. 3B). In terms of costimulatory molecules, we found a significant down-regulation in the 416 
levels of CD86 in DCs stimulated with mannan (Fig. 3C). It is interesting to note that CD86 417 
is one of the B7 family proteins, that has been previously associated with IDO induction (59, 418 
60). Furthermore, we have shown that MR engagement by mannan impairs Th1 cell priming 419 
induced by LPS, as evidenced by a significant suppression in IFN- production, which could 420 
bias T cell responses towards a Th2 profile (Fig. 3D, E, F). These data clearly suggest that 421 
reduction in IDO, through MR, could promote Th2 immune responses. 422 
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IDO has been well defined for its role in Th1 cell-mediated immune responses; however, its 423 
role in Th2 immune responses particularly in human has remained controversial (61). Some 424 
studies have shown that IDO can have a protective effect in different models of experimental 425 
asthma (19-24). This is in line with clinical studies showing that asymptomatic non-atopic 426 
individuals have higher systemic IDO activity than symptomatic atopic individuals (25, 26). 427 
Paradoxically, IDO expression might also contribute in mediating inflammatory responses in 428 
established Th2-mediated airway diseases. For example, a study with IDO knockout mice 429 
demonstrated that lack of IDO provide a significant relief from establishment of allergic 430 
airway disease (62), which could be due to impaired DC function in IDO deficient DCs (63, 431 
64). 432 
The aryl-hydrocarbon receptor (AhR) is a ligand-dependent transcription factor and a 433 
member of the Per-Arnt-Sim (PAS) superfamily of proteins, which are involved in the 434 
detection of environmental or intracellular changes. The interaction of AhR with Ah receptor 435 
nuclear translocator protein (ARNT) allows it to bind specific enhancer sequences present in 436 
target promoters called dioxin responsive elements (DREs) (27). Previously, AhR has been 437 
shown to have a protective role in allergy (65-68). Accordingly, in an attempt to elucidate the 438 
mechanism of TLR-4 and MR-mediated IDO modulation we studied the potential link 439 
between AhR and IDO in human DCs. Here, we have shown that TLR4-mediated induction 440 
of IDO is partially dependent on AhR expression (Fig. 5A). In addition, we have shown that 441 
the anti-inflammatory cytokine IL-10 is under AhR control, which highlights a central role 442 
for AhR in modulating DC mediated immune-suppression/regulation (Fig. 5C). Furthermore, 443 
we demonstrated that MR can down-regulate AhR expression and activity in the presence of 444 
LPS in human DCs (Fig. 5B), which could explain its effect on IDO expression (Fig. 4) and 445 
suppression of Th1 responses (Fig. 3). Interestingly, it has been shown that exogenous AhR 446 
ligands like 2,3,7,8-Tetrachlorodibenzodioxin (TCDD) can impair DC phenotype and 447 
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function (68-72) suppressing allergic sensitization (66, 68). Furthermore, metabolites 448 
produced in the IDO-dependent TRP degradation pathway, such as KYN and kynurenic acid, 449 
can activate AhR leading to Treg or Th17 differentiation depending on the immunological 450 
context (28, 73-75). Accordingly, we can speculate that IDO metabolites might have 451 
disparate effects in allergic responses, which will require further investigation.  452 
IDO induction has been shown to be under the control of the non-canonical NF-κB pathway 453 
(36, 42, 45). Additionally, the NF-κB together with AhR has been shown to be pivotal in 454 
TLR4 signaling (44, 76-78). Therefore, we evaluated the role of the NF-κB pathway in IDO 455 
regulation by MR. Using a protein microarray approach (35), we evaluated the expression of 456 
key components of the NF-κB pathway after stimulation with LPS in the presence and 457 
absence of mannan. Our data showed that stimulation with mannan and LPS can significantly 458 
down-regulate some key components of the non-canonical NF-κB pathway such as RelB, as 459 
well as the canonical NF-κB pathway such as phospho-p65 (Fig. 6A, B, C, D). Although a 460 
signalling motif has not been identified in MR cytoplasmic domain, members of the NF-κB 461 
signaling pathway have been previously implicated in MR-mediated signaling (43, 79). For 462 
instance, Man-LAM, most likely through binding to MR, mediates IRAK-M induction which 463 
acts as a negative regulator of the NF-κB pathway (43). Interestingly our preliminary data 464 
also shows that mannan stimulation reduces IRAK-M expression in the presence of LPS in 465 
human DCs (data not shown), which is in line with previous observations showing that 466 
IRAK-M might protect from complications of asthma, as Th2 cytokines decrease IRAK-M 467 
expression in macrophages (80). Collectively these observations highlight the role of the NF-468 
κB pathway in MR mediated IDO regulation in DCs. It is important to note that KYN via the 469 
AhR/SOCS2-dependet pathway can induce proteasome-mediated degradation of TRAF6, 470 
which might potentially inhibits TLR signalling favouring non-canonical NF-κB pathway 471 
(81). Additionally, an association between AhR and RelB has been suggested (82-84) that 472 
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might contribute to the stabilization of RelB complexes (85, 86). Accordingly, it is reasonable 473 
to suggest that AhR together with RelB might be involved in IDO regulation in human DCs, 474 
a pathway that is interfered after MR engagement. Future studies should aim at elucidating 475 
the potential physical association between AhR and RelB in regulating IDO levels.  476 
In conclusion, we have demonstrated that diverse airborne allergens can down-regulate IDO 477 
after TLR4 engagement and this effect was mainly mediated by MR. In addition, we have 478 
showed that AhR and RelB are implicated in MR-mediated IDO down-regulation suggesting 479 
a new pathway involved in inserting immune regulatory properties of allergens (Fig. 7). 480 
These data provide new insight into the initial steps of allergic sensitization which could pave 481 
the way for developing more effective therapeutic strategies targeting early events in the 482 
allergic cascade. 483 
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Figure Legends 801 
Figure 1. TLR4 agonist induces IDO1 and IDO2 in human dendritic cells. A. IDO activity in 802 
human DCs stimulated 24 hrs with increasing concentrations of LPS from E.coli O111:B4 803 
(n=5). B. IDO activity in human DCs stimulated 24 hrs with increasing concentrations of 804 
ultrapure LPS (n=2). C. IDO activity in human peripheral blood myeloid DCs stimulated 24 805 
hrs with LPS (0.01 µg/ml) (n=2). D. Conventional PCR analysis of IDO1 and IDO2 gene 806 
expression in human DCs stimulated 24 hrs with LPS 0.01 µg/ml. GAPDH was used as 807 
housekeeping gene. IDO1 (n=5), IDO2 (n=3). E. Flow cytometry analysis of IDO1 protein 808 
expression in human DCs stimulated 24 hrs with LPS 0.1 µg/ml. Grey filled histogram 809 
represent autofluorescence, black line represent isotype control and red histogram represent 810 
stained sample (n=5).  811 
Figure 2. TLR4-induction of IDO1 and IDO2 is down-regulated by allergens from diverse 812 
sources. A. IDO activity in human DCs stimulated 24 hrs with diverse allergen extracts (10 813 
µg/ml) in the presence and absence of LPS (0.01 µg/ml). German Cockroach (GC) extract 814 
from Blattella germanica, House Dust Mite (HDM) extract from Dermatophagoides 815 
pteronyssinus, Bermuda Grass Pollen (BGP) extract from Cynodon dactylon (n≥4). B. IDO 816 
activity in human DCs stimulated 24 hrs with mannan from Saccharomyces cerevisiae (M) 817 
(10 µg/ml) in the presence and absence of LPS (0.01 µg/ml) (n=5). C. qRT-PCR analysis of 818 
IDO1 and IDO2 gene expression in human DCs stimulated 24 hrs with M (10 µg/ml) in the 819 
presence of LPS (0.01 µg/ml). Relative expression of IDO1 and IDO2 were compared with 820 
that of GAPDH (n=3). In co-stimulation experiments, cells were stimulated with LPS 821 
followed immediately by allergen extracts. 822 
Figure 3. Mannose-based ligands down-regulate TLR4-induced IL-12p70 production by 823 
human dendritic cells and affect T helper cell polarization. A. Cytokine production by human 824 
36 
 
DCs stimulated or not with M followed by LPS for 24 hrs (n=3). B. IL-12 production by 825 
human DCs stimulated with several allergen extracts and LPS (n=3). C. Flow cytometry 826 
analysis of costimulatory molecules expression in human DCs stimulated 24 hrs with M and 827 
LPS (n=3). D. Percentage of IFN-γ positive cells (n=3). E. IFN-γ production by human T 828 
cells co-cultured with DCs stimulated or not with M followed by LPS (one experiment 829 
representative of three). F. DCs were stimulated or not with M and co-cultured in the 830 
presence of LPS with CD3+CD45RA+ naïve T cells. Polarization was assessed at day 6-8 by 831 
measuring IL-4 and IFN-γ production on CD4+ gated cells after re-stimulation with anti-832 
CD3/CD28 (one experiment representative of three).  833 
Figure 4. Mannose receptor mediates the IDO down-regulation by mannose-based ligands. 834 
A. IDO activity in CT and MRlow-DCs stimulated with M and LPS for 24 hrs (n=3). B. Flow 835 
cytometry analysis of MR and IDO1 protein expression in human DCs stimulated or not with 836 
M and LPS for 24 hrs. Median fluorescence intensity (MFI) values were normalized to 837 
control unstimulated sample (n=3). 838 
Figure 5. IDO regulation in human dendritic cells is partially dependent on AhR. A. IDO 839 
activity in CT and AhRlow-DCs stimulated or not with LPS for 24 hrs (n=3). B. qRT-PCR 840 
analysis of AhR and CYP1A1 gene expression in human DCs stimulated or not with M 841 
followed by LPS for 24 hrs. Relative expression of AhR and CYP1A1 were compared with 842 
that of GAPDH (n=3). C. IL-12p70 and IL-10 production by CT and AhRlow-DCs stimulated 843 
or not with LPS for 24 hrs (one experiment representative of three). 844 
Figure 6. The NF-κB pathway is negatively regulated by MR in human dendritic cells. A. 845 
Heat maps representing the relative abundance of proteins upstream the NF-κB signalling 846 
pathway using human DCs stimulated with M and LPS for different time points. B. Protein 847 
expression of phospho-p65, NIK and RelB in human DCs stimulated with M followed by 848 
37 
 
LPS. Data are shown as geometric mean of three independent experiments. C. Protein 849 
expression of RelB (90 min), NIK (90 min), phosphor-p65 (18 hrs) and TRAF3 (18 hrs) in 850 
human DCs stimulated with M followed by LPS. All fluorescent signals are reported as AFU 851 
with β-actin normalisation. D. qRT-PCR analysis of RelB gene expression in human DCs 852 
stimulated with M followed by LPS for 24 hrs. Relative expression of RelB was compared 853 
with that of GAPDH (n=2).  854 
Figure 7. MR-mediated IDO down-regulation in human DCs involved the transcription 855 
factors AhR and RelB, having an impact on T helper cell polarization.  856 
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Supplementary Figures 869 
Supplementary Figure 1. MR down-regulation by gene silencing. A. qRT-PCR analysis of 870 
MR gene expression in CT and MRlow-DCs. Relative expression of MR was compared with 871 
that of GAPDH (n=2). B. Flow cytometry analysis of MR protein expression. MFI is shown 872 
(n=5). C. Flow cytometry analysis of DC-SIGN, HLA-DR, TLR4, CD14, MD-2 and AhR 873 
protein expression. MFI is shown (n≥2).  874 
Supplementary Figure 2. AhR down-regulation by gene silencing. A. qRT-PCR analysis of 875 
AhR gene expression in CT and AhRlow-DCs. Relative expression of AhR was compared 876 
with that of GAPDH (n=2). B. Flow cytometry analysis of AhR protein expression in human 877 
CT-DCs compared with AhRlow-DCs. MFI is shown (n≥3). C. Flow cytometry analysis of 878 
MR, DC-SIGN, TLR4, CD14, MD-2 and CD86 protein expression. MFI is shown (n≥2). 879 
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Suppl Fig. 1 931 
 932 
 933 
 934 
 935 
 936 
 937 
 938 
 939 
Suppl Fig 2. 940 
45 
 
 941 
